Research for Angiostrongylus Cantonensis and Costaricensis in French West Indies and French Guiana
NCT03378882 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2020-12-11
Summary
Hospitals in the French West Indies (Fort-de-France (Martinique); Basse-Terre and Pointe-à-Pitre (Guadeloupe); and French Guiana (Cayenne, Saint-Laurent du Maroni)) have noted the emergence of eosinophilic meningitis cases in recent years. This finding is part os eosinophilic meningitis cases emergence and meningoencephalitis caused by the parasite Angiostrongylus cantonensis on the American continent and in the Greater Antilles.
In 2013, the investigation of an eosinophilic meningitis case by the Basse-Terre hospital team with a positive specific PCR in the CSF (CDC, Atlanta, USA) showed the first case of neuromeningeal angiostrongylosis in Guadeloupe. A similar case was diagnosed by serology at Pointe-à-Pitre University Hospital a few years earlier without having been published, and another serious case diagnosed also at Pointe-à-Pitre University Hospital Center in January 2017. The team at the Martinique University Hospital Center also reported several cases of eosinophilic meningitis with positive serologies for A. cantonensis carried out in laboratories outside Martinique (Laboratory of Parasitology, Gonesse, France; Thailand; and Tropical Institute and Public Health, Switzerland) in recent years.
The emergence of this parasitosis is related to the introduction of the intermediate host Achatina fulica on the American continent and the geographical evolution of the angiostrongylosis cases is intrinsically linked to that of the Achatins. To date, only two studies report the environmental presence of Angiostrongylus cantonensis in the Lesser Antilles. One proved the presence in rats (23.4%) on the island of Grenada, and the other in Guadeloupe, showing that 32.4% of Achatina fulica collected carried the parasite by specific PCR. In Martinique, where the number of cases is increasing, and in French Guiana, where there is an increase in the number of cases in neighboring countries, especially Brazil, no study has been conducted on this parasite.
In parallel with this finding, several serious digestive tables associated with strong hypereosinophilia were reported in Martinique and Guadeloupe in the 90s but also in recent years, the last case in December 2016. Etiological diagnoses were established by the discovery of Angiostrongylus costaricensis parasite in ileal pathological specimens. However, these cases could never be investigated by serology or specific PCR due to lack of diagnostic tools available in the French West Indies and Guiana region, and more broadly in metropolitan France.
Conditions
- Angiostrongylosis
- Hypereosinophilia
Interventions
- BIOLOGICAL
-
Parasitic serologies
Suspected angiostrongylosis - Angiostrongylus cantonensis: * An aliquot of CSF and an aliquot of serum will be sent to the laboratory of tropical medicine in Switzerland for research of specific antibodies. * A CSF aliquot will be sent to the CDC for PCR. Suspected angiostrongylosis- Angiostrongylus costaricensis: \- An aliquot of serum will be sent to the laboratory of tropical medicine in Switzerland for research of specific antibodies.
- PROCEDURE
-
Biopsy
Suspected angiostrongylosis - Angiostrongylus costaricensis: \- A piece of biopsy or intestinal resection will be sent to the pathology laboratory for parasitic elements suggestive of Angiostrongylus costaricensis infection
Sponsors & Collaborators
-
University Hospital Center of Pointe-à-Pitre/Abymes (Guadeloupe)
collaborator UNKNOWN -
Hospital Center of Basse-Terre (Guadeloupe)
collaborator UNKNOWN -
Hospital Center of Cayenne (French Guiana)
collaborator UNKNOWN -
Hospital Center of Saint-Laurent du Maroni (French Guiana)
collaborator UNKNOWN -
University Hospital Center of Martinique
lead OTHER
Principal Investigators
-
Nicole DESBOIS, MD · CHU of Martinique
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-03
- Primary Completion
- 2021-04-03
- Completion
- 2021-08-01
Countries
- France
More Related Trials
-
Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
NCT04035174 ·Status: WITHDRAWN ·Phase: NA
-
Schistosoma Mansoni Morbidity in Children Aged 1-5 Years
NCT01901484 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil
NCT00403611 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis
NCT05466630 ·Status: COMPLETED ·Phase: NA
-
Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in Gabon
NCT04326868 ·Status: COMPLETED ·Phase: PHASE4
-
Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar
NCT00713999 ·Status: COMPLETED ·Phase: NA
-
Diagnostic of Puumala Virus Infection in France
NCT02455375 ·Status: COMPLETED
-
Spontaneous Antigenemia in Loiasis
NCT04258670 ·Status: UNKNOWN
-
Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study
NCT06698510 ·Status: RECRUITING
-
Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
NCT06335160 ·Status: RECRUITING ·Phase: NA
-
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
NCT00906880 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
NCT04115072 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adoption of L-PZQ for Schistosomiasis by Endemic Counties - Social Science Research Study
NCT05350462 ·Status: ACTIVE_NOT_RECRUITING
-
Validation of INSPiRED Innovative Smart Diagnostic Devices for the Detection of Parasites Infections.
NCT04505046 ·Status: UNKNOWN
-
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
NCT00001645 ·Status: RECRUITING
-
Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network Approach
NCT06311344 ·Status: RECRUITING ·Phase: NA
-
New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease
NCT01755377 ·Status: COMPLETED
-
Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)
NCT02947581 ·Status: TERMINATED ·Phase: PHASE3
-
L-PZQ ODT in Schistosoma Infected Children
NCT03845140 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis
NCT02734186 ·Status: WITHDRAWN ·Phase: PHASE4
-
An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)
NCT02806232 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Intestinal Parasitic Infections in Under-Five Children With Malnutrition in Sohag, Egypt
NCT06716060 ·Status: RECRUITING
-
Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole
NCT02876146 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis
NCT05824442 ·Status: RECRUITING ·Phase: NA
-
Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana
NCT00463931 ·Status: COMPLETED